Abiopharma

New Form 4 - Royalty Pharma plc Filed: 2025-08-08 AccNo: 0001802768-25-000101 Size: 9 KB

New Form 4 - Elite Health Systems Inc. Filed: 2025-08-08 AccNo: 0001437749-25-025759 Size: 5 KB

New Form 4 - Elite Health Systems Inc. Filed: 2025-08-08 AccNo: 0001437749-25-025757 Size: 7 KB

New Form 4 - Elite Health Systems Inc. Filed: 2025-08-08 AccNo: 0001437749-25-025754 Size: 6 KB

New Form 4 - Mirum Pharmaceuticals, Inc. Filed: 2025-08-08 AccNo: 0001415889-25-021351 Size: 8 KB

New Form 4 - Elite Health Systems Inc. Filed: 2025-08-08 AccNo: 0001437749-25-025752 Size: 6 KB

New Form 4 - Mirum Pharmaceuticals, Inc. Filed: 2025-08-08 AccNo: 0001415889-25-021350 Size: 9 KB

New Form 10-Q - Edesa Biotech, Inc. Filed: 2025-08-08 AccNo: 0001171843-25-005236 Size: 5 MB

New Form 10-Q - CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. Filed: 2025-08-08 AccNo: 0001477932-25-005614 Size: 3 MB

New Form 10-Q - Turnstone Biologics Corp. Filed: 2025-08-08 AccNo: 0000950170-25-105957 Size: 10 MB

New Form 4 - SUPERNUS PHARMACEUTICALS, INC. Filed: 2025-08-08 AccNo: 0001628280-25-039308 Size: 6 KB

New Form 4 - QUEST DIAGNOSTICS INC Filed: 2025-08-08 AccNo: 0001497368-25-000005 Size: 10 KB

New Form 8-K - Edesa Biotech, Inc. Filed: 2025-08-08 AccNo: 0001171843-25-005235 Size: 291 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

UTHR: Notification

NEOG Investors Have Opportunity to Lead Neogen Corporation Securities Fraud Lawsuit